Benzimidazoles
Lansoprazole, 98+%
CAS: 103577-45-3 Molecular Formula: C16H14F3N3O2S Molecular Weight (g/mol): 369.362 MDL Number: MFCD00866873 InChI Key: MJIHNNLFOKEZEW-UHFFFAOYSA-N Synonym: lansoprazole,prevacid,bamalite,monolitum,lansoprazol,agopton,limpidex,ogastro,lanzor,opiren PubChem CID: 3883 ChEBI: CHEBI:6375 IUPAC Name: 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole SMILES: CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
Oxibendazole 98.0+%, TCI America™
CAS: 20559-55-1 Molecular Formula: C12H15N3O3 Molecular Weight (g/mol): 249.27 MDL Number: MFCD00133728 InChI Key: RAOCRURYZCVHMG-UHFFFAOYSA-N Synonym: Methyl (5-Propoxy-1H-benzo[d]imidazol-2-yl)carbamate, (5-Propoxy-1H-benzimidazol-2-yl)carbamic Acid Methyl Ester PubChem CID: 4622 IUPAC Name: methyl N-(6-propoxy-1H-benzimidazol-2-yl)carbamate SMILES: CCCOC1=CC2=C(C=C1)N=C(N2)NC(=O)OC
Medchemexpress LLC Albendazole sulfoxide | 54029-12-8 | 99.2% | 500 MG
Albendazole sulfoxide, also known as Ricobendazole, is the primary active metabolite of Albendazole. It demonstrates anti-parasite effects, specifically against Echinococcus multilocularis Metacestodes.
- Main active metabolite of Albendazole.
- Exhibits anti-parasite effect.
- Effective against Echinococcus multilocularis metacestodes.
- Demonstrates parasitocidal effect in vitro.
- Reduces cyst size and weight in vivo.
- Appears as a white to off-white solid.
- Soluble in DMSO.
Medchemexpress LLC Omeprazole | 73590-58-6 | 100.0% | C17H19N3O3S | 500 MG
Omeprazole is a proton pump inhibitor (PPI) used to treat acid-related gastrointestinal disorders. It works by competitively inhibiting CYP2C19 activity. Additionally, Omeprazole inhibits the growth of Gram-positive and Gram-negative bacteria and is identified as a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor. This acid-labile compound is used in the treatment of various conditions including dyspepsia, peptic ulcer disease, and gastroesophageal reflux disease.
- Proton pump inhibitor
- Competitively inhibits CYP2C19 activity (Ki of 2 to 6 μM)
- Inhibits growth of Gram-positive and Gram-negative bacteria
- Potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor
- Inhibits gastric acid secretion
- Used for treating acid-related gastrointestinal disorders
Medchemexpress LLC Omeprazole sodium | 95510-70-6 | MFCD07802816 | 99.10% | C17H18N3NaO3S | 500 MG
Omeprazole sodium is a proton pump inhibitor (PPI) used in the treatment of acid-related gastrointestinal disorders. It competitively inhibits CYP2C19 activity with a Ki of 2 to 6 μM. It also inhibits the growth of both Gram-positive and Gram-negative bacteria, and is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor).
- Proton pump inhibitor (PPI)
- Treats acid-related gastrointestinal disorders
- Competitively inhibits CYP2C19 activity with a Ki of 2 to 6 μM
- Inhibits growth of Gram-positive and Gram-negative bacteria
- Potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor)
- Utilized in the study of dyspepsia, peptic ulcer disease, gastroesophageal reflux disease, laryngopharyngeal reflux, and Zollinger-Ellison syndrome
Medchemexpress LLC Carbamic acid, N-[6-(phenylthio)-1H-benzimidazol-2-yl]-, methyl ester | 43210-67-9 | 99.9% | 500 MG
Fenbendazole is an orally active benzimidazole anthelmintic agent with a broad antiparasitic range. It functions as a microtubule destabilizing agent by binding to tubulin and disrupting the tubulin microtubule equilibrium. It stabilizes the transcriptional activator HIF-1α, exhibits efficient anti-proliferative activity, and induces apoptosis. This agent also causes cell-cycle arrest and mitotic cell death, demonstrating antitumor activity.
- Orally active benzimidazole anthelmintic agent
- Broad antiparasitic range
- Functions as a microtubule destabilizing agent
- Stabilizes transcriptional activator HIF-1α
- Exhibits anti-proliferative activity
- Induces apoptosis and causes cell-cycle arrest
- Demonstrates antitumor activity